Abstract:Backgroud/Aims: The aim of this study was to investigate the potential renoprotective effect of rapamycin on the autophagy of podocytes treated with the supernatant of mesangial cells cultured with aggregated IgA1 (aIgA1) from immunoglobulin A nephropathy (IgAN) patients.METHODS:Monomeric IgA1 (mIgA1) was isolated from the serum of IgAN patients or healthy volunteers, and then transformed to aIgA1 by heating. Subsequently, the aIgA1-mesangial cell supernatant was prepared by collecting the medium of mouse mesangial cells (MSC1097) cultured with aIgA1 (100 mg/L) from different IgAN patients or healthy volunteers for 48 h. Subsequently mouse podocytes (MPC5) were exposed to the supernatant of the aIgA1-mesangial cells for 24 h, using 100 mg/L aIgA1 from healthy volunteers as the control group or 100 mg/L aIgA1 from IgAN patients as the IgANs group, in RPMI 1640 medium. The MPC5 cells in the IgANs+Rap group were cultured with rapamycin (10 nmol/L) and the supernatant of MSC-1097 cells cultured with aIgA1 from IgAN patients in RPMI 1640 medium. Autophagy was assessed by western blot analysis (LC3, p62), electron microscopy, and immunofluorescence staining (LC3, p62, and CD63). The apoptosis of podocytes was evaluated by flow cytometry, and the expression of apoptosis-associated proteins cleaved-caspase-3 and caspase-3 were determined by western blot analysis.RESULTS:Deficient autophagy, which was evident by decreased LC3-II and CD63 levels, caused accumulation of p62, and fewer autophagosomes were observed in the MPC5 cells cultured with the IgAN supernatant, along with stronger expression of cleaved caspase-3 and a higher apoptosis rate. Inhibition of autophagy was alleviated in the IgANs+Rap group. The LC3-II/LC3-I ratio increased by almost 30%, the accumulated p62 amount was reduced by 50%, and the number of autophagosomes per podocyte increased to about 7 times that of the IgAN groups. These results were confirmed by immunofluorescence staining. In addition, the apoptosis rate of MPC5 cells decreased from 19.88% in the IgAN group to 16.78% in the IgANs+Rap group, which was accompanied by a weaker expression level of cleaved caspase-3.CONCLUSIONS:Rapamycin can reduce the apoptosis of podocytes by inducing autophagy in IgAN.

Rapamycin Induces Autophagy to Alleviate Acute Kidney Injury Following Cerebral Ischemia and Reperfusion Via the Mtorc1/atg13/ulk1 Signaling Pathway

Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and Mtor/ P70S6K/4EBP1 Signaling.

Rapamycin Induces Autophagy and Reduces the Apoptosis of Podocytes under a Stimulated Condition of Immunoglobulin A Nephropathy

Autophagy activation attenuates renal ischemia-reperfusion injury in rats.

Ischemic Postconditioning Protects Against Acute Kidney Injury after Limb Ischemia Reperfusion by Regulating HMGB1 Release and Autophagy.

Rapamycin Prevents Cerebral Stroke by Modulating Apoptosis and Autophagy in Penumbra in Rats

Rapamycin Protects Kidney Against Ischemia Reperfusion Injury Through Recruitment of NKT Cells.

Protective role of autophagy in rat renal ischemia-reperfusion injury and its related mecha-nisms

The roles of AMPK/mTOR autophagy pathway in the acute kidney injury-induced acute lung injury

The Post-Therapeutic Effect of Rapamycin in Mild Traumatic Brain-Injured Rats Ensuing in the Upregulation of Autophagy and Mitophagy.

The impact of rapamycin on renal ischemia reperfusion injury and repair in mice

Rapamycin ameliorates chronic intermittent hypoxia and sleep deprivation-induced renal damage via the mammalian target of rapamycin (mTOR)/NOD-like receptor protein 3 (NLRP3) signaling pathway

Role of rapamycin in protection against cerebral ischemia-induced brain injury is related to neurogenesis in discrete brain regions in rat

Rapamycin Enhances Mitophagy and Attenuates Apoptosis after Spinal Ischemia-Reperfusion Injury.

Protective Role of AMP-Activated Protein Kinase-Evoked Autophagy on an In Vitro Model of Ischemia/Reperfusion-Induced Renal Tubular Cell Injury

The Effect of Autophagy on Inflammation Cytokines in Renal Ischemia/Reperfusion Injury

Hollow Mesoporous Prussian Blue Nanoenzymes As Rapamycin Carrier for Targeted Treatment of Ischemia/reperfusion-Induced Acute Kidney Injury Through Pro-Mitophagy and Oxidative Stress Alleviation

Rapamycin prevents early steps of the development of diabetic nephropathy in rats.

Autophagy Activation is Associated with Neuroprotection Against Apoptosis Via a Mitochondrial Pathway in a Rat Model of Subarachnoid Hemorrhage

Inhibition of the JAK2/STAT3 Pathway and Cell Cycle Re-Entry Contribute to the Protective Effect of Remote Ischemic Pre-Conditioning of Rat Hindlimbs on Cerebral Ischemia/reperfusion Injury.

Inhibition of Mtor Pathway by Rapamycin Reduces Brain Damage in Rats Subjected to Transient Forebrain Ischemia